Search Results 371-380 of 17062 for pharmacogenetics
This research study is being done to create a collection of biospecimens (blood, urine, cyst fluid, bile, kidney or liver tissue, etc.) ...
The purpose of this study is to assess patients' understanding of the purpose and key components of the controlled substance agreement they signed in the ...
Aim 1: To determine the metabolic effects of decreasing circulating EOS in healthy subjects. Mepolizumab is an FDA-approved drug that selectively reduces ...
This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed multiple myeloma that are ...
The purpose of this study is to evaluate response, survival, safety, and tolerability of treatment with lenvatinib for patients who have anaplastic thyroid ...
The purpose of this study is to evaluate the safety and effectiveness of using Exablate Model 4000 Type-2.0/2.1 in adults with Glioblastoma brain tumors to ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Mayo Clinic Laboratories.
Mayo Clinic researcher Jonathan B. Hoyne, Ph.D., develops new laboratory tests for cancer, endocrine, autoimmune and neurological disorders.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!